Development and Application of Intelligent Diagnosis and Treatment Norms for Children and Adolescents With Mental Disorders
Launched by CHEN LI · Nov 23, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding and improving the diagnosis and treatment of mental health disorders in children and adolescents, specifically conditions like depression, anxiety, autism spectrum disorder (ASD), and attention deficit hyperactivity disorder (ADHD). With the increasing number of young people facing these challenges in China, the study aims to gather information about how common these disorders are, where they occur, and the characteristics of the affected children. By including over 12,000 participants under the age of 18, researchers hope to create a database that will help develop better, smarter ways to diagnose and treat these conditions.
To be eligible for this trial, children and teenagers must be diagnosed with depression, anxiety, ASD, or ADHD according to established guidelines and should be able to communicate and understand the study. Those with other serious mental or physical health issues or a history of substance abuse are not eligible. Participants can expect to take part in surveys and assessments that will contribute to a larger effort to create innovative solutions for early detection and treatment of mental health disorders in young people. This project is part of a broader initiative to improve mental health care in the Sichuan and Chongqing areas, utilizing technology to enhance diagnosis and intervention.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Depression patients:(1)Diagnose of depression according to DSM-5;Having the ability to act independently;Clear awareness;Able to communicate normally;Consent to the study ; (2)Under 18 years old;
- • Anxiety patients: (1)Diagnose of anxiety according to DSM-5;Having the ability to act independently;Clear awareness;Able to communicate normally;Consent to the study ; (2)Under 18 years old;
- • ASD patients:(1) Diagnose of ASD according to DSM-5;Do not have other neurological developmental disorders; (2)Under 18 years old;
- • ADHD patients: (1) Diagnose of ADHD according to DSM-5;Do not have other neurological developmental disorders; (2)Aged 4-18 years old;
- Exclusion Criteria:
- • suffering other mental illnesses and neurological disorders now or in the past
- • suffering severe physical illnesses now or in the past
- • substance or drug abuse now or in the past
About Chen Li
Chen Li is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative therapeutic solutions. With a focus on rigorous scientific methodology and adherence to regulatory standards, Chen Li collaborates with leading research institutions and healthcare professionals to design and implement clinical trials that address unmet medical needs. The organization prioritizes patient safety and ethical considerations, fostering an environment of transparency and accountability throughout the research process. Through its initiatives, Chen Li aims to contribute significantly to the development of effective treatments across various therapeutic areas.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chongqing, Chongqing, China
Patients applied
Trial Officials
Li Chen, doctor
Study Director
Children's Hospital of Chongqing Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported